Postoperative Pain Management in a Patient with Opioid Use Disorder
A 42-year-old man with a history of severe opioid use disorder (OUD) is admitted for an emergency appendectomy. He has been in sustained remission for 3 years on buprenorphine/naloxone 16/4 mg daily. He reports good adherence and has a stable job and family support. Postoperatively, he is in significant pain, and the surgical team consults you for pain management. He is anxious about relapse and wants to avoid full opioid agonists if possible. His vital signs are stable, and he has no signs of infection or other complications. The hospital formulary restricts immediate-release oxycodone but allows morphine and hydromorphone. The patient’s urine drug screen on admission was negative for illicit substances and positive for buprenorphine, as expected.
1. What is the most appropriate approach to managing this patient’s acute postoperative pain while maintaining his OUD treatment?
Read the worked answer
Continue buprenorphine/naloxone at the current dose (16/4 mg daily) and optimize non-opioid analgesia (e.g., scheduled acetaminophen and NSAIDs if not contraindicated, regional anesthesia if feasible). For breakthrough pain, use short-acting full opioid agonists (e.g., morphine or hydromorphone) at higher-than-usual doses, because buprenorphine’s high affinity and partial agonism at the mu-opioid receptor attenuate the analgesic effect of full agonists. Do not discontinue buprenorphine abruptly, as this risks withdrawal and relapse. If pain remains uncontrolled, consider increasing the buprenorphine dose (e.g., split dosing to 3-4 times daily) or, in severe cases, transitioning to a full agonist with careful monitoring. Avoid mixed agonist-antagonists (e.g., pentazocine) due to precipitated withdrawal. Coordinate with the surgical team and provide patient education about the plan.
2. The patient’s pain is poorly controlled on day 1 with scheduled acetaminophen and ibuprofen plus as-needed morphine 2 mg IV every 4 hours. What adjustments would you make?
Read the worked answer
Increase the morphine dose to 4-8 mg IV every 3-4 hours as needed, or switch to hydromorphone 0.5-1 mg IV every 3-4 hours. Because buprenorphine blocks full agonists, higher doses and more frequent administration may be necessary. Consider adding a buprenorphine dose in the evening (split dosing) to improve baseline analgesia. If pain is still severe, consult pain specialists for possible ketamine infusion or regional blocks. Monitor for oversedation and respiratory depression, especially with higher opioid doses. Reassess frequently and adjust. Ensure the patient remains on buprenorphine to prevent withdrawal and relapse. Document the rationale for using higher doses of full agonists in the presence of buprenorphine.
3. What discharge planning is essential to support this patient’s recovery and prevent relapse after surgery?
Read the worked answer
Before discharge, ensure the patient has a follow-up appointment with his OUD treatment provider within 1 week. Provide a limited supply of short-acting opioids (e.g., 3-5 days) with clear instructions and a plan to discontinue as pain improves. Avoid prescribing long-acting full agonists. Reconfirm continuation of buprenorphine/naloxone at the established dose. Educate the patient and family about signs of relapse and the importance of adherence to OUD treatment. Screen for mental health comorbidities and offer support. Coordinate with the outpatient provider to monitor pain and OUD. Consider a prescription drug monitoring program check. Provide naloxone and educate on overdose prevention. Emphasize non-opioid strategies and physical therapy as needed.